
|Articles|December 8, 2021
Supplements and Featured Publications
- Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone
- Volume 27
- Issue 20
eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes
Advertisement
Supplementary Appendix
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Votes to Extend ACA Subsidies, Eyes Turn to Senate
2
5 Key Health Care Changes During Trump’s First Year Back in Office
3
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
4
Disparities Drive Shifting Pancreatic Cancer Survival Trends
5




























































